Adam Binder
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- COVID-19 and healthcare impacts
- Cancer survivorship and care
- Lung Cancer Research Studies
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 25
- Neutropenia and Cancer Infections 8
- COVID-19 and healthcare impacts 8
- CAR-T cell therapy research 5
-
- Acute Lymphoblastic Leukemia research 8
- Co-authors
- Geoffrey R. Oxnard (1 shared paper)Pasi A. Jänne (1 shared paper)Joshua Brody (2 shared papers)Linda Hammerich (1 shared paper)Nathan Handley (10 shared papers)Arianna Heyer (3 shared papers)Rachel E. Granberg (3 shared papers)Kristin L. Rising (5 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Frontiers in Oncology (8 papers)Blood (8 papers)JCO Oncology Practice (5 papers)Transplantation and Cellular Therapy (4 papers)
- Partner nations
- United StatesGermany
In The Last Decade
Adam Binder
46 papers receiving 673 citations
Peers
Comparison fields: 5 of 94
- Oncology 323
- Cancer Research 101
- Immunology 136
- Pulmonary and Respiratory Medicine 199
- Public Health, Environmental and Occupational Health 139
Countries citing papers authored by Adam Binder
This map shows the geographic impact of Adam Binder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Binder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Binder more than expected).
Fields of papers citing papers by Adam Binder
This network shows the impact of papers produced by Adam Binder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Binder. The network helps show where Adam Binder may publish in the future.
Co-authors
The 25 scholars most cited alongside Adam Binder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 244 | |
| 2 | 2015 | 151 | |
| 3 | 2021 | 69 | |
| 4 | 1993 | 41 | |
| 5 | 2021 | 27 | |
| 6 | 2015 | 19 | |
| 7 | 2020 | 17 | |
| 8 | 2023 | 14 | |
| 9 | 2017 | 12 | |
| 10 | 2021 | 10 | |
| 11 | 2021 | 5 | |
| 12 | 2021 | 5 | |
| 13 | 2019 | 4 | |
| 14 | 2021 | 4 | |
| 15 | 2020 | 4 | |
| 16 | 2022 | 3 | |
| 17 | 2022 | 3 | |
| 18 | 2020 | 3 | |
| 19 | 2022 | 3 | |
| 20 | 2022 | 3 |
About Adam Binder
Adam Binder is a scholar working on Oncology, Public Health, Environmental and Occupational Health, Hematology, Genetics and Pathology and Forensic Medicine, having authored 56 papers that have together received 680 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (8 papers), Acute Lymphoblastic Leukemia research (8 papers), COVID-19 and healthcare impacts (8 papers), Lymphoma Diagnosis and Treatment (7 papers), Multiple Myeloma Research and Treatments (7 papers), Economic and Financial Impacts of Cancer (6 papers), CNS Lymphoma Diagnosis and Treatment (5 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Oncology (323 citations), Cancer Research (101 citations), Immunology (136 citations), Pulmonary and Respiratory Medicine (199 citations) and Public Health, Environmental and Occupational Health (139 citations). Adam Binder has collaborated with scholars based in United States and Germany. Frequent co-authors include Geoffrey R. Oxnard, Pasi A. Jänne, Joshua Brody, Linda Hammerich, Nathan Handley, Arianna Heyer, Rachel E. Granberg, Kristin L. Rising, Matthias Taupitz and Bernd Hamm. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, Blood, JCO Oncology Practice and Transplantation and Cellular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.